|
|
|
|
|
|
|
Array BioPharma Inc. (ARRY)
|
|
13.86 0.48 (3.59%)
|
08-21 16:00
|
|
Open:
|
13.46
|
Pre. Close:
|
13.38
|
|
High:
|
13.97
|
Low:
|
13.44
|
|
Volume:
|
2,301,422
|
Market Cap:
|
2934M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
13.99 - 14.068
|
14.068 - 14.14
|
|
Low:
|
13.235 - 13.337
|
13.337 - 13.43
|
|
Close:
|
13.711 - 13.86
|
13.86 - 13.997
|
|
|
|
Technical analysis (as of: 2018-08-21 4:22:41 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 18.48  One year: 20.29
|
|
Support:
|
Support1: 13.31 Support2: 11.07
|
|
Resistance:
|
Resistance1:
15.82 Resistance2: 17.37
|
|
Pivot:
|
14.62
|
|
Moving Averages:
|
MA(5): 13.86 MA(20): 14.86
MA(100): 15.88 MA(250): 14.23
|
|
MACD:
|
MACD(12,26):
-0.74 Signal(12,26,9): -0.66
|
|
%K %D:
|
%K(14,3): 12.97 %D(3): 14.08
|
|
RSI:
|
RSI(14): 34.52
|
|
52-Week:
|
High: 20.21
Low: 8.68 Change(%): 45.3
|
|
Average Vol(K):
|
3-Month: 264641
10-Days 256117
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ARRY has closed above bottom band by 20.1%. Bollinger Bands are 8.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-08-14T14:45:56-04:00
Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q4 2018 Results - Earnings Call Transcript
2018-08-14T09:07:03-04:00
Array BioPharma Inc. 2018 Q4 - Results - Earnings Call Slides
2018-08-14T08:04:12-04:00
Array BioPharma misses by $0.01, misses on revenue
2018-08-14T08:00:00-04:00
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
